GSK’s Emma Walmsley to be replaced as chief executive
NegativeWorld Affairs

In a surprising turn of events, GSK has announced that Emma Walmsley will step down as CEO after eight years, with chief commercial officer Luke Miels set to take over. This leadership change at one of Britain's largest drugmakers raises questions about the company's future direction and stability, especially given the challenges facing the pharmaceutical industry. Stakeholders will be watching closely to see how Miels navigates these turbulent waters.
— Curated by the World Pulse Now AI Editorial System